An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including OmicronBaoxue Quan, Shengyong Yang, Guifeng Lin et al.|Nature Microbiology|2022Cited by 101
A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variantsChong Huang, Shengyong Yang, Huiping Shuai et al.|Signal Transduction and Targeted Therapy|2023Cited by 82
Estimating the attributable burden of preterm birth and low birth weight due to maternal ozone exposure in nine Chinese citiesYin Yang, Hualiang Lin, Zhijiang Liang et al.|Atmospheric Environment|2019Cited by 16